Mandibulofacial dysostosis-microcephaly syndrome

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Mandibulofacial dysostosis-microcephaly syndrome | |
|---|---|
| Synonyms | MFDM syndrome |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Microcephaly, mandibulofacial dysostosis, developmental delay |
| Complications | N/A |
| Onset | Congenital |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation |
| Risks | Family history of the condition |
| Diagnosis | Genetic testing, clinical evaluation |
| Differential diagnosis | Treacher Collins syndrome, Nager syndrome |
| Prevention | N/A |
| Treatment | Supportive care, surgical intervention |
| Medication | N/A |
| Prognosis | Variable, depending on severity |
| Frequency | Rare |
| Deaths | N/A |
Mandibulofacial Dysostosis-Microcephaly Syndrome is a rare genetic disorder characterized by distinctive craniofacial abnormalities, microcephaly, and intellectual disability. This syndrome falls under the broader category of craniofacial syndromes, which involve malformations of the face and skull. The condition is also known as Treacher Collins syndrome type 2, highlighting its similarities to, yet distinct features from, the classic Treacher Collins syndrome.
Symptoms and Characteristics[edit]
The hallmark features of Mandibulofacial Dysostosis-Microcephaly Syndrome include:
- Microcephaly: A significantly smaller head size compared to others of the same age and sex.
- Craniofacial Abnormalities: These may include underdeveloped facial bones, particularly the mandible (lower jaw), leading to a characteristic facial appearance.
- Ear Abnormalities: Including underdeveloped or absent external ear structures, which may lead to hearing loss.
- Eyelid Abnormalities: Such as coloboma (a notch in the lower eyelid), which can affect vision.
- Intellectual Disability: Varying degrees of learning difficulties or cognitive impairment.
Genetics[edit]
Mandibulofacial Dysostosis-Microcephaly Syndrome is inherited in an autosomal recessive manner. This means that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the condition. The specific genes implicated in this syndrome have not been fully identified, making genetic counseling and prediction of the syndrome challenging.
Diagnosis[edit]
Diagnosis of Mandibulofacial Dysostosis-Microcephaly Syndrome is primarily based on clinical evaluation and the presence of characteristic physical features. Genetic testing may help in confirming the diagnosis, although the absence of identified specific genes can limit this approach.
Management and Treatment[edit]
There is no cure for Mandibulofacial Dysostosis-Microcephaly Syndrome, and treatment focuses on managing symptoms and improving quality of life. This may include:
- Surgical Interventions: To correct craniofacial abnormalities or to address hearing and vision problems.
- Educational Support: Tailored learning programs to accommodate intellectual disability.
- Therapeutic Support: Such as speech therapy, occupational therapy, and physical therapy to help with developmental milestones.
Prognosis[edit]
The prognosis for individuals with Mandibulofacial Dysostosis-Microcephaly Syndrome varies depending on the severity of symptoms. With appropriate medical and educational support, many affected individuals can lead fulfilling lives.
See Also[edit]
NIH genetic and rare disease info[edit]
Mandibulofacial dysostosis-microcephaly syndrome is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - Mandibulofacial dysostosis-microcephaly syndrome
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian